Purchases and Sales Made in Q3 2023 in Bluebird Bio, Inc. (BLUE)
This table provides information about the institutional ownership of Bluebird Bio, Inc. (BLUE) during Q3 2023. The information is specifically focused on institutions that hold shares of bluebird bio, Inc..
| Report Date | Institution (Fund) | Operation | Option | Shares change | Value Range | Shares Held | Trade History |
|---|---|---|---|---|---|---|---|
|
Nov 03, 2023
Q3 2023
|
Summit X, LLC
Chesterfield, MO |
SELL
|
- |
-60.1K- 27.01% |
$181K - $243K
|
162K
$60.1K
|
|
|
Nov 14, 2023
Q3 2023
|
Aqr Capital Management LLC
Greenwich, CT |
SELL
|
- |
-62.1K- 80.05% |
$188K - $252K
|
15.5K
$5.73K
|
|
|
Nov 13, 2023
Q3 2023
|
Credit Suisse Ag
Zurich, V8 |
SELL
|
- |
-67.1K- 3.62% |
$203K - $272K
|
1.78M
$660K
|
|
|
Nov 13, 2023
Q3 2023
|
Wells Fargo & Company
San Francisco, CA |
SELL
|
- |
-68.4K- 19.5% |
$207K - $277K
|
282K
$105K
|
|
|
Nov 14, 2023
Q3 2023
|
Jim Simons
Renaissance Technologies LLC | New York, Ny
|
SELL
|
- |
-75.3K- 13.69% |
$227K - $305K
|
475K
$176K
|
|
|
Nov 13, 2023
Q3 2023
|
Profund Advisors LLC
|
SELL
|
- |
-78.3K- 26.58% |
$237K - $317K
|
216K
$80.1K
|
|
|
Nov 14, 2023
Q3 2023
|
Jpmorgan Chase & CO
New York, NY |
SELL
|
- |
-93.5K- 5.3% |
$282K - $379K
|
1.67M
$618K
|
|
|
Nov 07, 2023
Q3 2023
|
Barclays PLC
London, X0 |
SELL
|
- |
-123K- 16.38% |
$371K - $498K
|
628K
$232K
|
|
|
Nov 09, 2023
Q3 2023
|
Group One Trading, L.P.
Chicago, IL |
SELL
|
- |
-131K- 16.49% |
$396K - $531K
|
665K
$246K
|
|
|
Nov 09, 2023
Q3 2023
|
Ubs Group Ag
|
SELL
|
- |
-131K- 31.33% |
$397K - $532K
|
288K
$107K
|
|
|
Oct 21, 2024
Q3 2023
|
Jump Financial, LLC
Chicago, IL |
SELL
|
- |
-201K- 90.43% |
$607K - $814K
|
21.3K
$7.87K
|
|
|
Nov 07, 2023
Q3 2023
|
Jump Financial, LLC
Chicago, IL |
SELL
|
- |
-201K- 90.43% |
$607K - $814K
|
21.3K
$7.87K
|
|
|
Nov 16, 2023
Q3 2023
|
Jacobs Levy Equity Management, Inc
Florham Park, NJ |
SELL
|
- |
-249K- 11.92% |
$753K - $1.01M
|
1.84M
$681K
|
|
|
Nov 14, 2023
Q3 2023
|
Goldman Sachs Group Inc
New York, NY |
SELL
|
- |
-298K- 28.13% |
$899K - $1.21M
|
761K
$281K
|
|
|
Nov 14, 2023
Q3 2023
|
Legal & General Group PLC
London, X0 |
SELL
|
- |
-307K- 74.75% |
$927K - $1.24M
|
104K
$38.4K
|
|
|
Nov 13, 2023
Q3 2023
|
Rafferty Asset Management, LLC
New York, NY |
SELL
|
- |
-346K- 18.83% |
$1.05M - $1.4M
|
1.49M
$552K
|
|
|
Nov 14, 2023
Q3 2023
|
Jane Street Group, LLC
New York, NY |
SELL
|
- |
-346K- 36.32% |
$1.05M - $1.4M
|
607K
$225K
|
|
|
May 14, 2024
Q3 2023
|
Goldman Sachs Group Inc
New York, NY |
SELL
|
- |
-516K- 40.41% |
$1.56M - $2.09M
|
761K
$281K
|
|
|
Nov 14, 2023
Q3 2023
|
Pfm Health Sciences, LP
San Francisco, CA |
SELL
|
- |
-1.24M- 17.08% |
$3.76M - $5.04M
|
6.04M
$2.24M
|
|
|
Nov 14, 2023
Q3 2023
|
State Street Corp
Boston, MA |
SELL
|
- |
-3.69M- 22.58% |
$11.2M - $15M
|
12.7M
$4.69M
|